Evelyn Partners Investment Management LLP

Source: SEC Form 13F · as of Mar 2026

Evelyn Partners Investment Management LLP holds 29 biotech & pharma companies tracked by BioSniper, totaling $441.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

29

Total value held

$441.4M

CompanySharesValue
AZNASTRAZENECA PLC1,675,125$325.5M
JNJJOHNSON & JOHNSON135,066$33.0M
ZTSZoetis Inc.231,709$27.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)95,509$25.8M
GEHCGE HealthCare Technologies Inc.147,330$10.5M
LLYELI LILLY & Co7,228$6.6M
ABTABBOTT LABORATORIES61,231$6.3M
MRKMerck & Co., Inc.13,690$1.6M
PFEPFIZER INC55,712$1.6M
ABBVAbbVie Inc.4,210$916K
PMPhilip Morris International Inc5,092$842K
INDVIndivior Pharmaceuticals, Inc.13,624$415K
BMYBRISTOL MYERS SQUIBB CO5,339$324K
NVSNovartis AG700$107K
GILDGILEAD SCIENCES, INC.766$107K
NVONovo Nordisk A/S2,765$102K
CRSPCRISPR Therapeutics AG1,300$62K
ALNYALNYLAM PHARMACEUTICALS, INC.175$58K
AMGNAMGEN INC113$40K
VTRSViatris Inc1,497$20K
ARVNARVINAS, INC.1,474$16K
ONCBeOne Medicines Ltd.41$12K
ZBHZimmer Biomet Holdings Inc.80$7K
IDXXIDEXX LABORATORIES INC /DE12$7K
APLSApellis Pharmaceuticals, Inc.150$6K
NEOGNEOGEN CORP554$5K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)167$3K
PRTAPROTHENA CORP PUBLIC LTD CO199$2K
SCLXSCILEX HOLDING CO5$33

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Evelyn Partners Investment Management LLP — Biotech 13F Holdings & Portfolio | BioSniper